| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1130-6343(07)75407-7 |
| P698 | PubMed publication ID | 18348666 |
| P50 | author | Jose Garnacho-Montero | Q56867748 |
| P2093 | author name string | S Grau Cerrato | |
| F Alvarez Lerma | |||
| O Rodríguez Colomo | |||
| P M Olaechea Astigarraga | |||
| E Cerdá Cerdá | |||
| M Palomar Martínez | |||
| P Muñoz García-Paredes | |||
| R Zaragoza Crespo | |||
| INfectious Diseases Working Group | |||
| Study Group on Infections in Critical Patients | |||
| P2860 | cites work | Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Endocarditis Treatment Consortium Group | Q77735516 |
| Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia | Q79811367 | ||
| [GEIPC-SEIMC (Study Group for Infections in the Critically Ill Patient of the Spanish Society for Infectious Diseases and Clinical Microbiology) and GTEI-SEMICYUC ( Working Group on Infectious Diseases of the Spanish Society of Intensive Medicine, C | Q80781822 | ||
| Lack of effect of combination antibiotic therapy on mortality in patients with pneumococcal sepsis | Q81332672 | ||
| Optimal antibiotic treatment in severe pneumococcal pneumonia--time for real answers | Q81393454 | ||
| Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia | Q22241905 | ||
| Antibiotic regimens for secondary peritonitis of gastrointestinal origin in adults | Q24246927 | ||
| Intensive care unit-acquired urinary tract infections in a regional critical care system | Q24811998 | ||
| Ventilator-associated pneumonia | Q28212947 | ||
| Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis | Q28333659 | ||
| Linezolid therapy of vancomycin-resistant Enterococcus faecium experimental endocarditis | Q28346136 | ||
| Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms | Q28374448 | ||
| The epidemiology of sepsis in the United States from 1979 through 2000 | Q29547760 | ||
| National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. | Q30977541 | ||
| Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study | Q31918107 | ||
| Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program | Q33346036 | ||
| Therapeutic efficacy of meropenem for treatment of experimental penicillin-resistant pneumococcal meningitis | Q33654490 | ||
| Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain | Q33770121 | ||
| Austrian syndrome caused by highly penicillin-resistant Streptococcus pneumoniae. | Q33787015 | ||
| Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection | Q33802451 | ||
| Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections | Q33836490 | ||
| Vancomycin-resistant enterococcal infections | Q33856515 | ||
| Linezolid against penicillin-sensitive and -resistant pneumococci in the rabbit meningitis model | Q33926998 | ||
| Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid | Q33942509 | ||
| Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study | Q33973732 | ||
| Cerebrospinal fluid penetration and pharmacokinetics of vancomycin administered by continuous infusion to mechanically ventilated patients in an intensive care unit | Q33979524 | ||
| Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections | Q33981016 | ||
| Practice guidelines for the management of bacterial meningitis | Q33982444 | ||
| Continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections: prospective multicenter randomized study | Q33982863 | ||
| Community-acquired bacterial meningitis in adults | Q33992706 | ||
| Pneumococcal meningitis in adults: new approaches to management and prevention | Q33994224 | ||
| Comparison of side effects of levofloxacin versus other fluoroquinolones | Q34090682 | ||
| Infective endocarditis--a prospective study at the end of the twentieth century: new predisposing conditions, new etiologic agents, and still a high mortality | Q34090891 | ||
| Intrapulmonary pharmacokinetics of linezolid | Q34106719 | ||
| Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam | Q34123811 | ||
| Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy | Q44901161 | ||
| Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings | Q44936182 | ||
| Impact of methicillin resistance on outcome of Staphylococcus aureus ventilator-associated pneumonia | Q44970315 | ||
| Clindamycin-resistant Streptococcus pyogenes: report of a case | Q44972457 | ||
| Linezolid eradicates MRSA better than vancomycin from surgical-site infections | Q45201834 | ||
| Impact of restricting fluoroquinolone prescription on bacterial resistance in an intensive care unit | Q45202613 | ||
| Quinolones for treatment of nosocomial pneumonia: a meta-analysis | Q45265797 | ||
| Levofloxacin for treatment of ventilator-associated pneumonia: a subgroup analysis from a randomized trial | Q45265798 | ||
| Clinical experience with linezolid for the treatment of central nervous system infections | Q46548640 | ||
| Staphylococcus aureus endocarditis: a consequence of medical progress | Q46561771 | ||
| Comparison of levofloxacin and cefotaxime combined with ofloxacin for ICU patients with community-acquired pneumonia who do not require vasopressors | Q46588967 | ||
| Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia | Q46589068 | ||
| Pneumonia caused by oxacillin-resistant Staphylococcus aureus treated with glycopeptides | Q46691587 | ||
| Evaluation of ceftriaxone, vancomycin and rifampicin alone and combined in an experimental model of meningitis caused by highly cephalosporin-resistant Streptococcus pneumoniae ATCC 51916. | Q46713332 | ||
| Linezolid versus vancomycin for Staphylococcus aureus bacteraemia: pooled analysis of randomized studies | Q46728767 | ||
| Monitoring of vancomycin serum levels for the treatment of staphylococcal infections | Q46929797 | ||
| Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia | Q46967041 | ||
| Combined treatment with ceftriaxone and linezolid of pneumococcal meningitis: a case series including penicillin-resistant strains | Q46980766 | ||
| Efficacy of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate (2000/125 mg) in adults with community-acquired pneumonia caused by Streptococcus pneumoniae, including penicillin-resistant strains. | Q47861588 | ||
| Short-course treatment of community-acquired pneumonia | Q48613116 | ||
| Acute abdomen in the medical intensive care unit. | Q50175711 | ||
| A randomised comparison of meropenem with cefotaxime or ceftriaxone for the treatment of bacterial meningitis in adults. Meropenem Meningitis Study Group. | Q50519159 | ||
| Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. | Q51643088 | ||
| Staphylococcus aureus prosthetic valve endocarditis: optimal management and risk factors for death. | Q52903319 | ||
| Enterococcal endocarditis in Sweden, 1995-1999: can shorter therapy with aminoglycosides be used? | Q53319709 | ||
| Treatment of gram-positive nosocomial pneumonia. Prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. Nosocomial Pneumonia Group. | Q53338170 | ||
| Treatment of hospitalized patients with complicated gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin. Synercid Skin and Skin Structure Infect | Q53343243 | ||
| Increase of resistance to macrolides in invasive Streptococcus pneumoniae in Spain (2000-2001). | Q53886063 | ||
| Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections. | Q54066894 | ||
| Comparison of patients with enterococcal bacteremia due to strains with and without high-level resistance to gentamicin. | Q54236593 | ||
| Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection | Q54262512 | ||
| Pulmonary disposition of vancomycin in critically ill patients. | Q54374101 | ||
| Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: Prospective randomized comparison with parenteral therapy | Q56798087 | ||
| Combination Antibiotic Therapy Lowers Mortality among Severely Ill Patients with Pneumococcal Bacteremia | Q57238018 | ||
| Streptococcus pneumoniae Endocarditis in Adults: A Multicenter Study in France in the Era of Penicillin Resistance (1991-1998) | Q59712590 | ||
| Steady-state trough serum and epithelial lining fluid concentrations of teicoplanin 12 mg/kg per day in patients with ventilator-associated pneumonia | Q61719294 | ||
| Drotrecogin Alfa (activated) Improves In-hospital and 90-day Survival in Patients With Severe Sepsis and Community-acquired Pneumoni | Q64028056 | ||
| Nosocomial infections in combined medical-surgical intensive care units in the United States | Q64130367 | ||
| Recomendaciones GEIPC-SEIMC y GTEI-SEMICYUC para el tratamiento antibiótico de infecciones por cocos grampositivos en el paciente crítico | Q64131294 | ||
| CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections | Q64135965 | ||
| Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone and netilmicin for 14 days: a prospective multicenter study | Q71373509 | ||
| Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy | Q71703052 | ||
| Prospective evaluation of a two-week course of intravenous antibiotics in intravenous drug addicts with infective endocarditis. Grupo de Estudio de Enfermedades Infecciosas de la Provincia de Cádiz | Q72370279 | ||
| Questionable history of immediate-type hypersensitivity to penicillin in Staphylococcal endocarditis: treatment based on skin-test results vers-us empirical alternative treatment--A decision analysis | Q73091315 | ||
| Rifampicin as an adjunct to vancomycin therapy in MRSA septicaemia in burns | Q73187536 | ||
| Meropenem alone and in combination with vancomycin in experimental meningitis caused by a penicillin-resistant pneumococcal strain | Q73484698 | ||
| Guide to development of practice guidelines | Q73613158 | ||
| Dilemmas in the treatment of invasive Streptococcus pyogenes infections | Q73715047 | ||
| Teicoplanin for skin and soft tissue infections: An open study and a randomized, comparative trial versus cefazolin | Q77544346 | ||
| Efficacy and tolerability of piperacillin/tazobactam versus ceftazidime in association with amikacin for treating nosocomial pneumonia in intensive care patients: a prospective randomized multicenter trial | Q43609282 | ||
| Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia | Q43781411 | ||
| Experimental study of the efficacy of vancomycin, rifampicin and dexamethasone in the therapy of pneumococcal meningitis | Q43895598 | ||
| Postoperative enterococcal infection after treatment of complicated intra-abdominal sepsis | Q43901109 | ||
| Successful use of oral linezolid as a single active agent in endocarditis unresponsive to conventional antibiotic therapy. | Q43965071 | ||
| Once-daily intravenous cefazolin plus oral probenecid is equivalent to once-daily intravenous ceftriaxone plus oral placebo for the treatment of moderate-to-severe cellulitis in adults | Q43996918 | ||
| Ertapenem once daily versus piperacillin-tazobactam 4 times per day for treatment of complicated skin and skin-structure infections in adults: results of a prospective, randomized, double-blind multicenter study | Q43996920 | ||
| Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections | Q43996924 | ||
| Effect of penicillin resistance of Streptococcus pneumoniae on the presentation, prognosis, and treatment of pneumococcal endocarditis in adults | Q44043634 | ||
| Empiric treatment of hospital-acquired lower respiratory tract infections with meropenem or ceftazidime with tobramycin: a randomized study. Meropenem Lower Respiratory Infection Group | Q44083251 | ||
| National Study of Control of Nosocomial Infection in Intensive Care Units. Evolutive report of the years 2003-2005 | Q44119047 | ||
| Treatment of ventilator-associated pneumonia with piperacillin-tazobactam/amikacin versus ceftazidime/amikacin: a multicenter, randomized controlled trial. VAP Study Group | Q44145974 | ||
| Enterococcal intravascular catheter-related bloodstream infection: management and outcome of 61 consecutive cases | Q44161010 | ||
| Linezolid versus ceftriaxone/cefpodoxime in patients hospitalized for the treatment of Streptococcus pneumoniae pneumonia | Q44175222 | ||
| Treatment of staphylococcal ventriculitis associated with external cerebrospinal fluid drains: a prospective randomized trial of intravenous compared with intraventricular vancomycin therapy | Q44439247 | ||
| Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: A multicenter, prospective, randomized, open-label study | Q44442591 | ||
| An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome | Q44510164 | ||
| Acute community-acquired bacterial meningitis in adults admitted to the intensive care unit: clinical manifestations, management and prognostic factors | Q44540765 | ||
| Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci | Q44573505 | ||
| MRSA pneumonia: better outcome through continuous infusion of vancomycin? | Q44616080 | ||
| Invasive group A streptococcal infections in Florida | Q44626208 | ||
| Once-weekly dalbavancin versus standard-of-care antimicrobial regimens for treatment of skin and soft-tissue infections | Q44635712 | ||
| Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study. | Q44719260 | ||
| Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin | Q44721295 | ||
| Linezolid compared with teicoplanin for the treatment of suspected or proven Gram-positive infections | Q44732971 | ||
| Treatment of multiresistant Staphylococcus epidermidis meningitis with linezolid | Q44794205 | ||
| Prospective observational study of bacteremic pneumococcal pneumonia: Effect of discordant therapy on mortality | Q44848498 | ||
| Antibiotic resistance in 3113 blood isolates of Staphylococcus aureus in 40 Spanish hospitals participating in the European Antimicrobial Resistance Surveillance System (2000-2002). | Q44884975 | ||
| Ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults: combined analysis of two multicentre randomized, double-blind studies | Q44901159 | ||
| Outcome and attributable mortality in critically Ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. | Q34155402 | ||
| Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia | Q34175100 | ||
| Penicillin-resistant Streptococcus pneumoniae endocarditis: a case report and review | Q34180292 | ||
| Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study | Q34268116 | ||
| Vancomycin-resistant enterococci: mechanisms and clinical observations | Q34289227 | ||
| Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolid: case report and review of the literature | Q34312876 | ||
| Complicated infections of skin and skin structures: when the infection is more than skin deep | Q34321629 | ||
| Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia | Q34329923 | ||
| The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections | Q34330270 | ||
| Streptococcal infections of skin and soft tissues | Q34368541 | ||
| Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Y | Q34426508 | ||
| Practice guidelines for the diagnosis and management of skin and soft-tissue infections | Q34460523 | ||
| Penicillins for treatment of pneumococcal pneumonia: does in vitro resistance really matter? | Q34476601 | ||
| Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia | Q34783668 | ||
| The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia | Q34999299 | ||
| Clinical study of 44 cases of Staphylococcus aureus meningitis | Q35044347 | ||
| Right-sided endocarditis caused by Staphylococcus aureus in drug abusers. | Q35111909 | ||
| A practical guide to the treatment of complicated skin and soft tissue infections | Q35166376 | ||
| Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin | Q35533543 | ||
| Enterococcal meningitis: a clinical study of 39 cases and review of the literature. | Q35552813 | ||
| Treatment of meningitis due to methicillin-resistant Staphylococcus epidermidis with linezolid | Q36240752 | ||
| Continuous versus intermittent intravenous administration of antibacterials with time-dependent action: a systematic review of pharmacokinetic and pharmacodynamic parameters | Q36316972 | ||
| Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. | Q36409465 | ||
| Gram-positive cocci infections in intensive care: guide to antibacterial selection | Q36480958 | ||
| Evolution of the antimicrobial resistance of Staphylococcus spp. in Spain: five nationwide prevalence studies, 1986 to 2002. | Q37598683 | ||
| Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults | Q37868241 | ||
| Acute bacterial meningitis in adults. A review of 493 episodes | Q39411298 | ||
| Linezolid for the treatment of central nervous system infections in neurosurgical patients | Q39559123 | ||
| Synergistic effect of amoxicillin and cefotaxime against Enterococcus faecalis | Q39780375 | ||
| Isolation of Staphylococcus aureus from the urinary tract: association of isolation with symptomatic urinary tract infection and subsequent staphylococcal bacteremia | Q40368236 | ||
| An analysis of 110 serious enterococcal infections. Epidemiology, antibiotic susceptibility, and outcome. | Q40453188 | ||
| Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. | Q40558538 | ||
| Short-course antibiotic therapy for right-sided endocarditis caused by Staphylococcus aureus in injection drug users | Q40642288 | ||
| Review of pneumococcal endocarditis in adults in the penicillin era. | Q41696153 | ||
| Risk factors for neurosurgical site infections after craniotomy: a prospective multicenter study of 2944 patients. The French Study Group of Neurosurgical Infections, the SEHP, and the C-CLIN Paris-Nord. Service Epidémiologie Hygiène et Prévention | Q42055347 | ||
| Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis. A randomized, controlled trial | Q42551854 | ||
| Once-daily, high-dose levofloxacin versus ticarcillin-clavulanate alone or followed by amoxicillin-clavulanate for complicated skin and skin-structure infections: a randomized, open-label trial | Q42681448 | ||
| Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility | Q43433837 | ||
| Telavancin versus standard therapy for treatment of complicated skin and soft-tissue infections due to gram-positive bacteria | Q43553034 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 353-369 | |
| P577 | publication date | 2007-11-01 | |
| P1433 | published in | Farmacia hospitalaria : órgano oficial de expresión científica de la Sociedad Española de Farmacia Hospitalaria | Q26842251 |
| P1476 | title | [Summary of the GEIPC-SEIMC and GTEI-SEMICYUC recommendations for the treatment of infections caused by gram positive cocci in critical patients] | |
| P478 | volume | 31 |
| Q46033219 | [Vancomycin or linezolid as the treatment of choice for grampositive nosocomial pneumonia] | cites work | P2860 |
Search more.